organophosphonates has been researched along with Degenerative Diseases, Central Nervous System in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, I; Cho, JH; Song, HO | 1 |
Berghuis, AM; De Schutter, JW; Gormley, P; Hu, Z; Leung, CY; Lin, YS; Park, J; Poirier, J; Tsantrizos, YS | 1 |
Georgantas, V; Iordanidis, L; Jakusch, T; Kiss, T; Kotsakis, N; Raptopoulou, CP; Salifoglou, A; Terzis, A; Zervou, M | 1 |
Araújo, WL; Bettendorff, L; Bunik, VI; Fernie, AR; Strokina, AA; Trofimova, LK | 1 |
4 other study(ies) available for organophosphonates and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Mitochondrial Uncoupling Attenuates Age-Dependent Neurodegeneration in C. elegans.
Topics: 2,4-Dinitrophenol; Aging; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Disease Models, Animal; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Uncoupling Proteins; Mitophagy; Mutation; Neurodegenerative Diseases; Organophosphonates; Piperazines | 2017 |
Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases.
Topics: Allosteric Site; Alzheimer Disease; Catalytic Domain; Crystallography, X-Ray; Diphosphonates; Drug Evaluation, Preclinical; Enzyme Inhibitors; Geranyltranstransferase; Humans; Ligands; Neurodegenerative Diseases; Organophosphonates; Phosphorylation; Polymorphism, Single Nucleotide; Pyrimidines; tau Proteins | 2014 |
Synthetic, structural and solution speciation studies on binary Al(III)-(carboxy)phosphonate systems. Relevance to the neurotoxic potential of Al(III).
Topics: Aluminum; Crystallography, X-Ray; Etidronic Acid; Humans; Imino Acids; Ligands; Magnetic Resonance Spectroscopy; Neurodegenerative Diseases; Neurons; Organophosphonates | 2009 |
Consequences of the α-ketoglutarate dehydrogenase inhibition for neuronal metabolism and survival: implications for neurodegenerative diseases.
Topics: Animals; Carbohydrates; Cells, Cultured; Citric Acid Cycle; Enzyme Inhibitors; Ketoglutarate Dehydrogenase Complex; Metabolome; Mitochondria; Models, Biological; Neurodegenerative Diseases; Neurons; Organophosphonates; Oxidation-Reduction; Rats; Succinates | 2012 |